Pyridostigmine for treatment of neurogenic orthostatic hypertension
- 1 February 2005
- journal article
- clinical trial
- Published by Springer Nature in Clinical Autonomic Research
- Vol. 15 (1) , 51-53
- https://doi.org/10.1007/s10286-005-0225-3
Abstract
We report the result of a follow-up, open-label study of pyridostigmine for treatment of orthostatic hypotension. Aim of the study was to evaluate self-reported efficacy and patients' satisfaction with the medication. Most patients were very satisfied with the medication and chose to continue it.Keywords
This publication has 9 references indexed in Scilit:
- Acetylcholinesterase inhibition: a novel approach in the treatment of neurogenic orthostatic hypotensionJournal of Neurology, Neurosurgery & Psychiatry, 2003
- Association Between Supine Hypertension and Orthostatic Hypotension in Autonomic FailureHypertension, 2003
- A double-blind, dose-response study of midodrine in neurogenic orthostatic hypotensionNeurology, 1998
- The Hypertension of Autonomic Failure and Its TreatmentHypertension, 1997
- Effects of Volume Loading and Pressor Agents in Idiopathic Orthostatic TachycardiaCirculation, 1997
- Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, double-blind multicenter study. Midodrine Study Group.1997
- Efficacy of Midodrine vs Placebo in Neurogenic Orthostatic HypotensionJAMA, 1997
- Gastrointestinal motility disturbances in patients with orthostatic hypotensionGastroenterology, 1985
- Mineralocorticoid-Induced Hypertension in Patients with Orthostatic HypotensionNew England Journal of Medicine, 1979